Cigna Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 4.33%

Cigna Corporation EBITDA Margin is 4.33% for the Trailing 12 Months (TTM) ending March 31, 2025, a 4.91% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Cigna Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 4.13%, a -40.37% change year over year.
  • Cigna Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 6.92%, a 11.87% change year over year.
  • Cigna Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 6.19%, a -33.44% change year over year.
  • Cigna Corporation EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 9.30%, a 27.45% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin